Dr. Reddy's Laboratories intimates exchanges of its Q4 FY26 earnings call transcript filing.
The transcript details the quarterly and annual results discussion held on May 12, 2026.
The document is a regulatory compliance filing pursuant to SEBI LODR Regulations.
The transcript has been made publicly available on the company's official website.